ALQGC — Quantum Genomics SA Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: Quantum Genomics Enrolls First Patient In REFRESH Study
Brief: Quantum Genomics Secures 3 Million Euros Non-Dilutive Financing
Brief: Quantum Genomics Ends Collaboration With Qilu On Firibastat In China
Brief: Quantum Genomics FY Operating Loss Widens To 13.9 Million Euros
Brief: Quantum Genomics' Equity Stake Acquired By Orient EuroPharma
Brief: Quantum Genomics Launches Phase III Pivotal REFRESH Study In Difficult-To-Treat/Resistant Hypertension With Once-A-Day Formulation Of Firibastat
Brief: Quantum Genomics Signs Strategic Contract With Delpharm
Brief: Quantum Genomics Enters Into Exclusive Licensing And Collaboration Agreement With Faran
Brief: Quantum Genomics Raises 20 Million Euros Through A Private Placement
Brief: Quantum Genomics Launches Capital Increase Of Around EUR 16 Mln
Brief: Quantum Genomics Enters Into Exclusive Agreement With Dongwha Pharm
Brief: Quantum Genomics Announces End Of Financing Agreement With Negma Group Ltd/Park Partners
Brief: Quantum Genomics Enters Into Exclusive Agreement With Xediton Pharmaceuticals
Brief: Quantum Genomics Enters Exclusive Agreement With Qilu Pharmaceutical
Brief: Quantum Genomics H1 Net Loss Widens To 5.1 Million Euros
Brief: Quantum Genomics Enters Exclusive Licensing Agreement With OEP
Brief: Quantum Genomics: Information On Financing Contract With Negma Group
Brief: Quantum Genomics Updates on Phase III Hypertension Study
Brief: Quantum Genomics Announces Interim Analysis From Renal Failure Study